Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 1/2017

01-02-2017 | Therapeutic Aspects in Autoimmunity

An idiopathic thrombocytopenic purpura with polyneuropathy

Authors: Valeria Katchan, Paula David, Yehuda Shoenfeld

Published in: Immunologic Research | Issue 1/2017

Login to get access

Abstract

Concurrent association of idiopathic thrombocytopenic purpura (ITP) and peripheral neuropathy is a rare condition. There are only few case reports published concerning peripheral neuropathy with ITP. One of the etiopathogenetic mechanisms proposed is intraneural hemorrhage, but the pathogenesis is not fully understood. Autoimmune nature with common antibodies to the platelets and the nerve´s myelin sheath should also be considered. Here we describe a 47-year-old woman, with a family history of autoimmune diseases. She was diagnosed 2 years ago with ITP and later developed a chronic combined inflammatory demyelinating polyneuropathy. Treatment with high-dose steroids was initiated with a poor response. The patient showed a clear improvement in platelet count and in the peripheral neuropathy symptoms when treatment with intravenous immunoglobulin was administered. Common etiologic mechanism of the two diseases should be considered, both, because of the simultaneous time of development and a similar response to intravenous immunoglobulin treatment.
Literature
1.
Greenberg Michael K, Sonoda T. Mononeuropathy multiplex complicating idiopathic thrombocytopenic purpura. Neurology. 1991;41:1517–818.CrossRef
2.
3.
Bigelow NH, Graves RN. Peripheral nerve lesions in hemorrhagic diseases. Arch Neurol Psychiat. 1952;68:819–30.CrossRef
4.
Brun A, Caviness V, Rudnick P, Tayler HR. Hemorrhages into peripheral nerves in association with leukemia. J Neuropathol Exp Neurol. 1964;23:719–25.CrossRefPubMed
5.
Cordinegley FT, Crawford GPM. Ulnar nerve palsy in the haemophiliac due to intraneural haemorrhage. Br Med J. 1984;289:18–9.CrossRef
6.
Miyao S, Takano A, Teramoto J, Fujitake S, Hashizume Y. Oculomotor nerve palsy due to intraneural hemorrhage in idiopathic thrombocytopenic purpura: a case report. Eur Neurol. 1993;33:20–2.CrossRefPubMed
7.
Gianpolo Antony J, Giuliani Michael J. ITP and neuropathy. To the editor. Neurology. 1993;43:847.CrossRef
8.
Ward IM, Fewell AE, Ferraro DM, Morris MJ. Concurrent acute motor and sensory axonal neuropathy and immune thrombocytopenic purpura. Mil Med. 2013;178(3):e367.CrossRefPubMed
9.
Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:3–7.PubMed
10.
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, Freire de Carvalho J, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:8–12.PubMed
11.
Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Eric Gershwin M. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J. 2008;10:13–9.PubMed
12.
13.
Sato N, Kamata T, Akiyama N, Kuwana M, Kanda T. Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura. J Intern Med. 2005;257:473–7.CrossRefPubMed
14.
Harati Y, Bosch EP. Disorders of peripheral nerves. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Bradley’s neurology in clinical practice, vol. 2, 5th ed. Philadelphia: Butterworth-Heinemann Elsevier; 2008. p. 2288–2296.
15.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.CrossRefPubMed
16.
Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. Eur J Neurol. 2010;17:356.CrossRefPubMed
17.
Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78:1009.CrossRefPubMed
18.
Godeau B, Chevret S, Varet B, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002;359:23.CrossRefPubMed
19.
Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195.CrossRefPubMed
20.
Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994;36:838.CrossRefPubMed
21.
Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;12:CD001797.
22.
Godeau B, Caulier MT, Decuypere L, et al. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. Br J Haematol. 1999;107:716.CrossRefPubMed
23.
Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol. 2009;158(Suppl 1):43–50.CrossRefPubMedPubMedCentral
24.
Shoenfeld Y, Fishman P. Gamma-globulin inhibits tumour spread in mice. Int Immunol. 1999;11:1247–51.CrossRefPubMed
25.
Shapiro S, Shoenfeld Y, Gilburd B, et al. Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer. 2002;95:2032–7.CrossRefPubMed
26.
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386.CrossRefPubMed
27.
Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960.CrossRefPubMed
28.
George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3.PubMed
29.
Toltl LJ, Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol. 2011;152:52.CrossRefPubMed
30.
Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445.CrossRefPubMed
31.
Cornblath DR, Gorson KC, Hughes RA, Merkies IS. Observations on chronic inflammatory demyelinating polyneuropathy: a plea for a rigorous approach to diagnosis and treatment. J Neurol Sci. 2013;330:2.CrossRefPubMed
32.
Gorson KC, van Schaik IN, Merkies IS, et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst. 2010;15:326.CrossRefPubMed
33.
Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78:1079.CrossRefPubMed
34.
Pollard JD, Armati PJ. CIDP—the relevance of recent advances in Schwann cell/axonal neurobiology. J Peripher Nerv Syst. 2011;16:15–23.CrossRefPubMed
35.
Dacci P, Riva N, Scarlato M, et al. Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report. Neural Sci. 2010;31:829–31.CrossRef
36.
Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Federation of management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst. 2010;15:295–301.CrossRef
37.
38.
Léger JM, Viala K, Cancalon F, et al. Intravenous Immunoglobulin as short- and long-term therapy for multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. J Neural Neurosurg Psychiatry. 2008;79:93–6.CrossRef
39.
Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain. 2002;125:1875–86.CrossRefPubMed
40.
Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy? Neurology. 2004;62:666–8.CrossRefPubMed
41.
Vucic S, Black KR, Chong PS, Cros D. Multifocal neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology. 2004;63:1264–9.CrossRefPubMed
Metadata
Title
An idiopathic thrombocytopenic purpura with polyneuropathy
Authors
Valeria Katchan
Paula David
Yehuda Shoenfeld
Publication date
01-02-2017
Publisher
Springer US
Published in
Immunologic Research / Issue 1/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8828-4

Other articles of this Issue 1/2017

Immunologic Research 1/2017 Go to the issue

GUEST EDITORIAL

Novel clinical and therapeutic aspects in autoimmunity

Mechanism in Autoimmunity

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Environment and Autoimmunity

Is the immune neuroendocrine system the connection between epipharyngitis and chronic fatigue syndrome induced by HPV vaccine?

Therapeutic Aspects in Autoimmunity

Glaucoma: recent advances in the involvement of autoimmunity

Mechanism in Autoimmunity

Irregular antibodies in no hemolytic autoimmune diseases are able to induce erythrophagocytosis

Environment and Autoimmunity

Guillain–Barré syndrome in Colombia: where do we stand now?